阻塞性睡眠呼吸暂停低通气综合征与血脂紊乱关系的研究进展

doi:10.6040/j.issn.1673-3770.0.2021.078

摘要/Abstract

摘要： 阻塞性睡眠呼吸暂停低通气综合征是常见的睡眠呼吸障碍疾病之一,与脂代谢紊乱均为影响人类健康的重要慢性疾病。两种疾病联系紧密,均与心脑血管疾病的发展密切相关,危害性极大,故受到广泛关注。就阻塞性睡眠呼吸暂停低通气综合征对血脂紊乱影响可能的病理生理机制和临床相关研究的最新进展进行综述。

关键词: 睡眠呼吸暂停低通气综合征, 血脂紊乱, 间歇缺氧, 睡眠片段化, 脂蛋白

Abstract: Obstructive sleep apnea-hypopnea syndrome(OSAHS)is a common sleep apnea disorder. Both OSAHS and lipid metabolism disorders are important chronic conditions affecting human health, and they are closely related to the development of cardiovascular and cerebrovascular diseases. This article will review the possible pathophysiological mechanisms underlying the effect of OSAHS on dyslipidemia and the progress of related clinical research.

Key words: Sleep apnea-hypopnea syndrome, Dyslipidemia, Intermittent hypoxia, Sleep fragmentation, Lipoproteins

中图分类号:

R766.7

杨晰珺,关建，吴海莺. 阻塞性睡眠呼吸暂停低通气综合征与血脂紊乱关系的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 133-138.

YANG Xijun, GUAN Jian,WU Haiying. Research progress on the relationship between obstructive sleep apnea-hypopnea syndrome and dyslipidemia[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 133-138.

参考文献

[1] Dempsey JA, Veasey SC, Morgan BJ, et al. Pathophysiology of sleep apnea[J]. Physiol Rev, 2010, 90(1): 47-112. doi:10.1152/physrev.00043.2008.
[2] Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. doi:10.1016/s2213-2600(19)30198-5.
[3] Fu Y, Xia Y, Yi H, et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment[J]. Sleep Breath, 2017, 21(1): 181-189. doi:10.1007/s11325-016-1393-1.
[4] Murphy AM, Thomas A, Crinion SJ, et al. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation[J]. Eur Respir J, 2017, 49(4): 160-173. doi:10.1183/13993003.01731-2016.
[5] Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study[J]. Am J Epidemiol, 2001, 154(1): 50-59. doi:10.1093/aje/154.1.50.
[6] Svatikova A, Wolk R, Gami AS, et al. Interactions between obstructive sleep apnea and the metabolic syndrome[J]. Curr Diab Rep, 2005, 5(1): 53-58. doi:10.1007/s11892-005-0068-2.
[7] Trzepizur W, Le Vaillant M, Meslier N, et al. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia[J]. Chest, 2013, 143(6): 1584-1589. doi:10.1378/chest.12-1652.
[8] Perry JC, D'Almeida V, Souza FG, et al. Consequences of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats[J]. Respir Physiol Neurobiol, 2007, 156(3): 250-258. doi:10.1016/j.resp.2006.10.004.
[9] Li JG, Savransky V, Nanayakkara A, et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia[J]. J Appl Physiol Bethesda Md, 2007, 102(2): 557-563. doi:10.1152/japplphysiol.01081.2006.
[10] Li JG, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice[J]. Circ Res, 2005, 97(7): 698-706. doi:10.1161/01.RES.0000183879.60089.a9.
[11] Li JG, Nanayakkara A, Jun J, et al. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia[J]. Physiol Genomics, 2007, 31(2): 273-280. doi:10.1152/physiolgenomics.00082.2007.
[12] Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism[J]. Prog Lipid Res, 2004, 43(2): 91-104. doi:10.1016/s0163-7827(03)00039-0.
[13] Li JG, Bosch-Marce M, Nanayakkara A, et al. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha[J]. Physiol Genomics, 2006, 25(3): 450-457. doi:10.1152/physiolgenomics.00293.2005.
[14] Savransky V, Jun J, Li JG, et al. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase[J]. Circ Res, 2008, 103(10): 1173-1180. doi:10.1161/CIRCRESAHA.108.178533.
[15] Choi SH, Ginsberg HN. Increased very low density lipoprotein(VLDL)secretion, hepatic steatosis, and insulin resistance[J]. Trends Endocrinol Metab, 2011, 22(9): 353-363. doi:10.1016/j.tem.2011.04.007.
[16] Jun J, Reinke C, Bedja D, et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice[J]. Atherosclerosis, 2010, 209(2): 381-386. doi:10.1016/j.atherosclerosis.2009.10.017.
[17] Weiszenstein M, Shimoda LA, Koc M, et al. Inhibition of lipolysis ameliorates diabetic phenotype in a mouse model of obstructive sleep apnea[J]. Am J Respir Cell Mol Biol, 2016, 55(2): 299-307. doi:10.1165/rcmb.2015-0315oc.
[18] Xiong YL, Qu Z, Chen N, et al. The local corticotropin-releasing hormone receptor 2 signalling pathway partly mediates hypoxia-induced increases in lipolysis via the cAMP-protein kinase A signalling pathway in white adipose tissue[J]. Mol Cell Endocrinol, 2014, 392(1/2): 106-114. doi:10.1016/j.mce.2014.05.012.
[19] Kirby DA, Pinto JM, Weiss JW, et al. Effects of beta adrenergic receptor blockade on hemodynamic changes associated with obstructive sleep apnea[J]. Physiol Behav, 1995, 58(5): 919-923. doi:10.1016/0031-9384(95)00150-h.
[20] Roberts AC, Butterfield GE, Cymerman A, et al. Acclimatization to 4, 300-m altitude decreases reliance on fat as a substrate[J]. J Appl Physiol(1985), 1996, 81(4): 1762-1771. doi:10.1152/jappl.1996.81.4.1762.
[21] Pilz S, Scharnagl H, Tiran B, et al. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography[J]. Eur Heart J, 2007, 28(22): 2763-2769. doi:10.1093/eurheartj/ehm343.
[22] Pulawa LK, Jensen DR, Coates A, et al. Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle[J]. J Lipid Res, 2007, 48(1): 145-151. doi:10.1194/jlr.M600384-JLR200.
[23] Luyster FS, Kip KE, Drumheller OJ, et al. Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B[J]. J Clin Sleep Med, 2012, 8(2): 155-161. doi:10.5664/jcsm.1768.
[24] Drager LF, Li J, Shin MK, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea[J]. Eur Heart J, 2012, 33(6): 783-790. doi:10.1093/eurheartj/ehr097.
[25] Yao QL, Shin MK, Jun JC, et al. Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues[J]. J Lipid Res, 2013, 54(4): 1058-1065. doi:10.1194/jlr.M034272.
[26] Ekstedt M, Akerstedt T, Söderström M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure[J]. Psychosom Med, 2004, 66(6): 925-931. doi:10.1097/01.psy.0000145821.25453.f7.
[27] Brindley DN, McCann BS, Niaura R, et al. Stress and lipoprotein metabolism: modulators and mechanisms[J]. Metabolism, 1993, 42(9 Suppl 1): 3-15. doi:10.1016/0026-0495(93)90255-m.
[28] Carreras A, Zhang SX, Peris E, et al. Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea[J]. Int J Obes(Lond), 2015, 39(3): 418-423. doi:10.1038/ijo.2014.181.
[29] Gündüz C, Basoglu OK, Hedner J, et al. Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database[J]. Respirology, 2018, 23(12): 1180-1189. doi:10.1111/resp.13372.
[30] Guan J, Yi HL, Zou JY, et al. Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study[J]. Thorax, 2016, 71(4): 347-355. doi:10.1136/thoraxjnl-2015-207403.
[31] Bikov A, Lazar Z, Horvath P, et al. Association between serum lipid profile and obstructive respiratory events during REM and non-REM sleep[J]. Lung, 2019, 197(4): 443-450. doi:10.1007/s00408-019-00195-7.
[32] Xu HJ, Xia YY, Li XY, et al. Association between obstructive sleep apnea and lipid metabolism during REM and NREM sleep[J]. J Clin Sleep Med, 2020, 16(4): 475-482. doi:10.5664/jcsm.8242.
[33] Tokuda F, Sando Y, Matsui H, et al. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome[J]. Intern Med, 2008, 47(21): 1843-1849. doi:10.2169/internalmedicine.47.1035.
[34] Drager LF, Bortolotto LA, Maki-Nunes C, et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome[J]. Atherosclerosis, 2010, 208(2): 490-495. doi:10.1016/j.atherosclerosis.2009.08.016.
[35] Qian Y, Yi H, Zou J, et al. Independent association between sleep fragmentation and dyslipidemia in patients with obstructive sleep apnea[J]. Sci Rep, 2016, 6: 26089. doi:10.1038/srep26089.
[36] Zhao X, Li X, Xu H, et al. Relationships between cardiometabolic disorders and obstructive sleep apnea: Implications for cardiovascular disease risk[J]. J Clin Hypertens(Greenwich), 2019, 21(2): 280-290. doi:10.1111/jch.13473.
[37] Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome[J]. Diabetes Obes Metab, 2007, 9(5): 679-687. doi:10.1111/j.1463-1326.2006.00649.x.
[38] Steiropoulos P, Tsara V, Nena E, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome[J]. Chest, 2007, 132(3): 843-851. doi:10.1378/chest.07-0074.
[39] Börgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels[J]. Eur Respir J, 2006, 27(1): 121-127. doi:10.1183/09031936.06.00131304.
[40] Simon B, Gabor B, Barta I, et al. Effect of 5-year continuous positive airway pressure treatment on the lipid profile of patients with obstructive sleep apnea: a pilot study[J]. J Sleep Res, 2020, 29(2): e12874. doi:10.1111/jsr.12874.
[41] Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2007, 176(7): 706-712. doi:10.1164/rccm.200703-500OC.
[42] Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial[J]. Lung, 2009, 187(1): 17-22. doi:10.1007/s00408-008-9115-5.
[43] Phillips CL, Yee BJ, Marshall NS, et al. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial[J]. Am J Respir Crit Care Med, 2011, 184(3): 355-361. doi:10.1164/rccm.201102-0316OC.
[44] Xu HJ, Yi HL, Guan J, et al. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials[J]. Atherosclerosis, 2014, 234(2): 446-453. doi:10.1016/j.atherosclerosis.2014.03.034.
[45] Lin MT, Lin HH, Lee PL, et al. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis[J]. Schlaf Atmung, 2015, 19(3): 809-817. doi:10.1007/s11325-014-1082-x.
[46] 葛晓辉, 王宁宇, 占小俊, 等. 手术对阻塞性睡眠呼吸暂停低通气综合征患者血脂代谢变化的临床观察[J]. 山东大学耳鼻喉眼学报, 2017,31(1): 27-30. doi: 10.6040/j.issn.1673-3770.0.2016.197. GE Xiaohui, WANG Ningyu, ZHAN Xiaojun, et al. Serum lipid changes in obstructive sleep apnea hypopnea syndrome patients underwent airway surgery[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017,31(1): 27-30. doi: 10.6040/j.issn.1673-3770.0.2016.197.
[47] Qian YJ, Zou JY, Xu HJ, et al. Association of upper airway surgery and improved cardiovascular biomarkers and risk in OSA[J]. Laryngoscope, 2020, 130(3): 818-824. doi:10.1002/lary.28012.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed